Skip to main content
. 2018 Apr 30;26(8):1083–1093. doi: 10.1038/s41431-018-0143-1

Table 1.

Overview on diseases caused by SMARCB1 germline variants

Atypical teratoid/rhabdoid tumor (AT/RT) Rhabdoid tumor of the kidney (RTK) Malignant rhabdoid tumor (MRT) Multifocal rhabdoid tumor Schwannoma Meningioma SCCOHT Other tumors Coffin–Siris syndrome Nicolaides–Baraitser syndrome Unaffected carriers Total
Number of cases 115 13 25 39 89 37 26 12 119 64 38 577
Affected gene SMARCB1 109 12 24 39 89 23 0 12 14 0 17 339
SMARCA4 6 1 1 0 0 0 26 0 12 0 14 60
SMARCA2 0 0 0 0 0 0 0 0 4 64 0 68
SMARCE1 0 0 0 0 0 14 0 0 6 0 7 27
ARlD1A 0 0 0 0 0 0 0 0 8 0 0 8
ARlD1B 0 0 0 0 0 0 0 0 69 0 0 69
ARlD2 0 0 0 0 0 0 0 0 6 0 0 6

One patient may represent several cases if he developed more than one disease. Other tumors encompass cribriform neuroepithelial tumor (CRINET, n = 3), malignant peripheral nerve sheath tumor (MPNST, n = 2), conventional chondrosarcoma (n = 1), epitheloid sarcoma (n = 1), myeloid sarcoma (n = 1), leiomyosarcoma (n = 1), papillary renal cell carcinoma (pRCC1, n = 1), leiomyoma (n = 1), and myoepithelioma (n = 1).